Lv7
3620 积分 2024-05-24 加入
Design and Synthesis of Novel Mitochondria-Targeted HDAC3 Inhibitors for the Treatment of Obesity
8天前
已完结
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA 1 ) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)
20天前
已完结
Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial
20天前
已完结
Effect of Admilparant, a Lysophosphatidic Acid Receptor 1 Antagonist, on Disease Progression in Pulmonary Fibrosis
21天前
已完结
Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278
1个月前
已完结
Neutral LPAR1 Antagonists for the Treatment of Idiopathic Pulmonary Fibrosis
1个月前
已完结
Can GLP-1s heal the brain? Obesity drugs get a makeover for addiction and depression
1个月前
已完结
Production of a Chimeric Form of CD23 That Is Oligomeric and Blocks IgE Binding to the FcεRI
1个月前
已完结
Mast Cell and Basophil Cell Lines: A Compendium
1个月前
已完结
IgE, IgE Receptors and Anti-IgE Biologics: Protein Structures and Mechanisms of Action
1个月前
已完结